{{Rsnum
|rsid=17036023
|Gene=IGSF3
|Chromosome=1
|position=116587089
|Orientation=plus
|GMAF=0.03949
|Gene_s=IGSF3
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 98.2 | 1.8 | 0.0
| HCB | 100.0 | 0.0 | 0.0
| JPT | 98.2 | 1.8 | 0.0
| YRI | 66.0 | 31.9 | 2.1
| ASW | 82.5 | 17.5 | 0.0
| CHB | 100.0 | 0.0 | 0.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 66.1 | 31.2 | 2.8
| MEX | 96.6 | 3.4 | 0.0
| MKK | 74.8 | 23.2 | 1.9
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23829686
  |Trait=Asthma (childhood onset)
  |Title=Rank-based genome-wide analysis reveals the association of ryanodine receptor-2 gene variants with childhood asthma among human populations.
  |RiskAllele=
  |Pval=5E-6
  |OR=NR
  |ORtxt=NR
  |OA=1
}}

{{on chip | Affy GenomeWide 6}}